Fluidigm Announces Conference Call and Webcast of Third Quarter 2018 Financial Results
October 01, 2018 16:15 ET
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Oct. 01, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), a leader in mass cytometry and microfluidics technologies, announced today that it will report...
Cytek Biosciences Adds Investors, Completes Series C Financing
September 25, 2018 10:00 ET
|
Cytek Biosciences
FREMONT, Calif., Sept. 25, 2018 (GLOBE NEWSWIRE) -- Cytek Biosciences Inc., the preeminent provider of innovative flow cytometry solutions, today announced the completion of a Series C funding round...
CARsgen Therapeutics and CrownBio complete CAR-T study for gastric cancer
September 13, 2018 08:00 ET
|
Crown Bioscience
SAN DIEGO, Sept. 13, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience, a global drug discovery and development services company providing translational platforms to advance oncology, inflammation,...
Fluidigm Partners with GenomOncology to Provide a Comprehensive Immuno-Oncology Gene Expression Solution on Biomark HD
September 07, 2018 07:30 ET
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Sept. 07, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) and GenomOncology today announced an expanded Immuno-Oncology Gene Expression Workflow to...
Fluidigm to Participate at Upcoming Investor Events in September
September 05, 2018 18:00 ET
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Sept. 05, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ: FLDM), a leader in mass cytometry and microfluidics technologies, announced today that the company’s...
VBI Vaccines to Present at the 20th Annual Rodman & Renshaw Global Investment Conference
August 28, 2018 08:00 ET
|
VBI Vaccines, Inc.
CAMBRIDGE, Mass., Aug. 28, 2018 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (NASDAQ:VBIV) (“VBI”), a commercial-stage biopharmaceutical company developing next-generation infectious disease and...
MolecularMD Launches Validated Tumor Mutation Burden Assay for Immuno-Oncology Clinical Trial Services
August 22, 2018 05:00 ET
|
MolecularMD
PORTLAND, Ore., Aug. 22, 2018 (GLOBE NEWSWIRE) -- MolecularMD today announces it has validated Thermo Fisher Scientific’s Oncomine™ Tumor Mutation Load Assay for clinical research trials to aid...
Third Dosing Cohort to be initiated in MAGE-A4 SPEAR T-cell Basket Study After Favorable Review of Safety from One Billion Cell Dose Cohort
August 15, 2018 07:30 ET
|
Adaptimmune Therapeutics plc
PHILADELPHIA and OXFORD, United Kingdom, Aug. 15, 2018 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in T-cell therapy to treat cancer, today announced a favorable review...
CrownBio erweitert gentechnisch veränderte Modellauswahl durch strategische Partnerschaft mit dem Shanghai Model Organisms Center (SMOC)
August 14, 2018 23:50 ET
|
Crown Bioscience
SAN DIEGO, Aug. 15, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience, ein globales Unternehmen im Bereich der Forschung und Entwicklung von Arzneimitteln, das translationale Plattformen zur...
CrownBio étend sa sélection de modèles génétiquement modifiés grâce à une alliance stratégique avec le Shanghai Model Organisms Center (SMOC)
August 14, 2018 23:50 ET
|
Crown Bioscience
SAN DIEGO, 15 août 2018 (GLOBE NEWSWIRE) -- Crown Bioscience, une société mondiale de services de recherche et de développement de médicaments fournissant des plateformes translationnelles en...